Alice Notley, Poet Celebrated for ‘Restless Reinvention,' Dies at 79
Her sons, the poets Edmund and Anselm Berrigan, said she died in a hospital from a cerebral hemorrhage. She had been in treatment for ovarian cancer.
Hailed as 'one of America's greatest poets' by the Poetry Foundation, Ms. Notley published more than 40 books over five decades. Her autobiographical collection 'Mysteries of Small Houses' was a Pulitzer Prize finalist in 1999 and won the Los Angeles Times Book Prize for Poetry in 1998. She received the Ruth Lilly Poetry Prize from the Poetry Foundation for lifetime achievement in 2015.
Ms. Notley took traditional forms of poetry like villanelles and sonnets and laced them with experimental language that fluctuated between vernacular speech and dense lyricism. She also created pictorial poetry, or calligrams, in which she contorted words into fantastical shapes. In her 2020 collection, 'For the Ride,' one calligram took the form of a winged coyote.
'The signature of her work is a restless reinvention and a distrust of groupthink that remains true to her forebear's directive: to not give a damn,' David S. Wallace wrote in The New Yorker in 2020.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Heidi Klum says the biggest misconception about being a woman over 50 is that 'you are off the shelf'
Heidi Klum, 52, says women over 50 aren't "off the shelf" and shouldn't shrink themselves with age. "We are very much on that shelf for everyone to see. Don't hide in your 50s," Klum said. She joins public figures like Lauren Sánchez Bezos and Chelsea Handler in speaking positively about aging. Heidi Klum is 52, embracing her wrinkles, and still posing in lingerie, because she said she doesn't think aging is anything to be ashamed of. In an interview with People published on Monday, the supermodel spoke about marriage, motherhood, and what it's like to age in the spotlight. Klum told People that she is pushing back against the assumption that women in their 50s lose relevance because of their age. "The biggest misconception [about] being in your 50s is that you are off the shelf. You're not off the shelf," Klum said. "We are very much on that shelf for everyone to see. Don't hide in your 50s." The "Project Runway" host added that beauty evolves with time, and she's "here for the change." "If it's always the same, life is boring," she said. Klum, who has four kids with her ex-husband Seal, isn't afraid to show off her body either. "I've been photographing nude or in lingerie since 1992, way before Instagram," Klum said. "So for me, it's nothing new. For the past 15 years, other people are now doing what I've been doing for 30 years. Instead of being in my little bottoms in a magazine, I'm on Instagram. It's the same thing." It doesn't matter that she's older, she said: "I don't have this age-shaming or body-shaming thing. I feel like everyone should do what they want to do. I like to run around sexy — even now at 52." But it does help to see how perspectives on aging have shifted in recent years, she added. "Now it's OK to be older — but it didn't use to be like that," she says. "I feel like we're more welcoming of wrinkles and rolls on our body. Being accepted at every age is amazing. That we've changed and come all that way," Klum said. She said she isn't opposed to getting cosmetic enhancements like Botox. Still, she said she sees aging as something to look forward to. "Don't we all want to get old? I know we always say that, but it's the truth. I'm already looking at 60 and 70, hopefully 80 and 90. And if we're still kicking it then, let's celebrate," Klum said. A representative for Klum did not immediately respond to a request for comment sent by Business Insider outside regular hours. Klum joins a growing list of famous women speaking candidly and optimistically about growing older. In November, Lauren Sánchez Bezos said she never expected to have so much to look forward to after turning 50. "When I was 20, I thought, 'Oh my gosh, life is over at 50.' Let me tell you: It is not, ladies. It is not over," she said during a "Today" show appearance. In January, Chelsea Handler said she isn't afraid of growing older and is excited for all that her 50s would offer. "My life is exactly what I hoped it would be — it's more than I hoped it would be. I had no idea what the possibilities were or that I could live a life like this and feel so free," Handler told Parade. Read the original article on Business Insider Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
Heidi Klum says the biggest misconception about being a woman over 50 is that 'you are off the shelf'
Heidi Klum, 52, says women over 50 aren't "off the shelf" and shouldn't shrink themselves with age. "We are very much on that shelf for everyone to see. Don't hide in your 50s," Klum said. She joins public figures like Lauren Sánchez Bezos and Chelsea Handler in speaking positively about aging. Heidi Klum is 52, embracing her wrinkles, and still posing in lingerie, because she said she doesn't think aging is anything to be ashamed of. In an interview with People published on Monday, the supermodel spoke about marriage, motherhood, and what it's like to age in the spotlight. Klum told People that she is pushing back against the assumption that women in their 50s lose relevance because of their age. "The biggest misconception [about] being in your 50s is that you are off the shelf. You're not off the shelf," Klum said. "We are very much on that shelf for everyone to see. Don't hide in your 50s." The "Project Runway" host added that beauty evolves with time, and she's "here for the change." "If it's always the same, life is boring," she said. Klum, who has four kids with her ex-husband Seal, isn't afraid to show off her body either. "I've been photographing nude or in lingerie since 1992, way before Instagram," Klum said. "So for me, it's nothing new. For the past 15 years, other people are now doing what I've been doing for 30 years. Instead of being in my little bottoms in a magazine, I'm on Instagram. It's the same thing." It doesn't matter that she's older, she said: "I don't have this age-shaming or body-shaming thing. I feel like everyone should do what they want to do. I like to run around sexy — even now at 52." But it does help to see how perspectives on aging have shifted in recent years, she added. "Now it's OK to be older — but it didn't use to be like that," she says. "I feel like we're more welcoming of wrinkles and rolls on our body. Being accepted at every age is amazing. That we've changed and come all that way," Klum said. She said she isn't opposed to getting cosmetic enhancements like Botox. Still, she said she sees aging as something to look forward to. "Don't we all want to get old? I know we always say that, but it's the truth. I'm already looking at 60 and 70, hopefully 80 and 90. And if we're still kicking it then, let's celebrate," Klum said. A representative for Klum did not immediately respond to a request for comment sent by Business Insider outside regular hours. Klum joins a growing list of famous women speaking candidly and optimistically about growing older. In November, Lauren Sánchez Bezos said she never expected to have so much to look forward to after turning 50. "When I was 20, I thought, 'Oh my gosh, life is over at 50.' Let me tell you: It is not, ladies. It is not over," she said during a "Today" show appearance. In January, Chelsea Handler said she isn't afraid of growing older and is excited for all that her 50s would offer. "My life is exactly what I hoped it would be — it's more than I hoped it would be. I had no idea what the possibilities were or that I could live a life like this and feel so free," Handler told Parade. Read the original article on Business Insider
Yahoo
an hour ago
- Yahoo
Lilly set for strong quarter after Novo profit warning
By Patrick Wingrove and Bhanvi Satija (Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term health. Lilly's weight-loss drug Zepbound leads the U.S. market and has faced less competition from cheaper copies made by compounding pharmacies, giving it an edge, they said, after investors wiped $70 billion from Novo's market value. Novo, which sells the obesity drug Wegovy and related diabetes medicine Ozempic, on Tuesday issued a profit warning, citing lower U.S. growth expectations and competition including from compounded versions. "I think that this is a pretty positive report for Lilly just because it shows the competitive note it has against their largest competitor," said Dave Wagner, portfolio manager at Aptus Capital Advisors. Analysts expect Lilly to post second-quarter earnings of $5.57 per share on revenue of $14.71 billion, according to LSEG data. They are also looking for a full-year profit of $21.83 per share. Lilly has forecast adjusted earnings of $20.78 to $22.28 per share for 2025. Still, Lilly's shares fell nearly 5% on Tuesday, reflecting concern that the company could be vulnerable if Novo cuts prices aggressively or if its growth in the obesity market also slows more than expected, analysts and investors said. Zepbound holds just under 60% of the obesity market, while Lilly's diabetes drug Mounjaro - containing the same active ingredient - accounts for over half of its segment against Ozempic, according to IQVIA data shared with Reuters by an analyst. IQVIA did not immediately respond to a request for confirmation. UBS analyst Trung Huynh said data also showed Lilly was getting around two-thirds of new patients onto Zepbound. The company in December posted results from a large head-to-head trial showing patients on Zepbound lost an average of 20.2% of their weight after 72 weeks compared to 13.7% for the group treated with Wegovy. Lilly is also expected to be first to the market with the next generation of oral obesity drugs. Lilly has said it intends to seek approval for its experimental drug orforglipron by the end of the year. Lilly has felt less heat from compounded versions of its medicines than Novo Nordisk, Huynh said, largely because Wegovy and Ozempic both hit the market before Lilly's drugs and built up patient recognition sooner. Compounding pharmacies earlier this year were restricted under U.S. law from making drugs that were essentially copies of Wegovy and Zepbound, but can still make personalized doses for patients who need them, or formulations not offered by FDA-approved medicines. Investors earlier this year were rattled by CVS Health's decision to drop Zepbound from some lists of medicines it covers for reimbursement starting on July 1, triggering a 10% share price plunge. But Lilly's stock has declined marginally so far this year, compared to a more than 40% fall in Novo Nordisk's shares, including Tuesday's moves. Barclays analyst Emily Field said Lilly could calm investors next week by reaffirming or boosting revenue and profit outlooks, or simply by delivering strong financial results. Brian Mulberry at Zacks Investment Management said signs of softness in the obesity or diabetes drug market, especially from a peer like Novo, typically trigger broad-based selling, which might account for Lilly's share drop on Tuesday. Sign in to access your portfolio
